
Keywords
Clinical Conditions
Equipment & Techniques
As Innovation Pathway Manager (Proof-of-Concept) at Cambridge NeuroWorks and the University of Cambridge, my work focuses on supporting the translation of early-stage neurotechnology research towards proof-of-concept and future impact. Through the Blue Sky Proof-of-Concept Fund and Blue Sky Fellowship programme, I work with and support researchers developing innovative solutions to major challenges in neuroscience and neurotechnology, spanning areas including Parkinson's disease, mental health and emerging neurotechnologies. My research has focused on gene therapy and regenerative neurobiology, with particular interests in neuronal development, axon regeneration and gene delivery to the nervous system. Key research areas include: 1) Developmental neurobiology: Investigating neuronal maturation and its impact on intrinsic axon growth. 2) Gene therapy: Optimising the delivery of transgenes to the nervous system using adeno-associated viral vectors. 3) Axon regeneration: Identifying and validating potential targets to promote axon regeneration in CNS neurons.
The Axonal Growth Cone
